Quoin Pharmaceuticals, INC.
Development and commercialization of therapeutic drug products that treat rare diseases.
Based in VA
🤖
AI Overview
With $60K in lobbying spend across 5 quarterly filings, Quoin Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 3 issue areas.
$60K
Total Spend
1
Years Active
1
Firms Hired
3
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2025 | $60K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED, Pharmacy
- •Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
American Society of Consultant Pharmacists
$425K total spend
Healthcare Distribution Alliance (Formerly - Hdma)
$13.2M total spend
Infectious Diseases Society of America
$5.1M total spend
Community Oncology Alliance
$3.2M total spend
Healthcare Distribution Alliance (Healthcare Distribution Managment Assn.)
$2.9M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.